Pain Management

• FDA approval · 2026-08-14
  FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Camber Pharmaceuticals, Inc.)

  Supplemental approval for a generic buprenorphine/naloxone product by Camber Pharmaceuticals, Inc. (ANDA 219850).

• FDA approval · 2025-04-02
  FDA Approved: LIDOCAINE HYDROCHLORIDE — Original Application (Anthea Pharma Private Limited)

  FDA approved a generic lidocaine hydrochloride product from Anthea Pharma Private Limited under an Original Application (ANDA 219535).